Insulet

$265.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.78 (-1.77%) As of 8:46 PM UTC today

Why Robinhood?

You can buy or sell Insulet and other stocks, options, and ETFs commission-free!

About PODD

Insulet Corporation Common Stock, also called Insulet, is a medical device company. The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA. The listed name for PODD is Insulet Corporation Common Stock.

CEO
Shacey Petrovic
Employees
1,350
Headquarters
Acton, Massachusetts
Founded
2000
Market Cap
17.76B
Price-Earnings Ratio
2.51K
Dividend Yield
—
Average Volume
489.49K
High Today
$271.87
Low Today
$259.28
Open Price
$270.29
Volume
236.93K
52 Week High
$298.43
52 Week Low
$121.00

PODD Earnings

-$0.26
-$0.10
$0.06
$0.22
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.04 per share
Actual
-$0.26 per share
Replay Earnings Call

You May Also Like

LCYAW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure